UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 138

Sortiert nach

Survivin as a preferential target for cancer therapy

International Journal of Molecular Sciences, 2014-02, Vol.15 (2), p.2494-2516

2014

Link zum Volltext

Verfügbarkeit prüfen

The Developmental Origins of Cancer: A Review of the Genes Expressed in Embryonic Cells with Implications for Tumorigenesis

Genes, 2023-02, Vol.14 (3), p.604

2023

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a 21-gene prognostic signature in neuroblastoma

Scientific reports, 2023-08, Vol.13 (1), p.12526-12526, Article 12526

2023

Link zum Volltext

Verfügbarkeit prüfen

The hepatocyte growth factor/mesenchymal epithelial transition factor axis in high-risk pediatric solid tumors and the anti-tumor activity of targeted therapeutic agents

Frontiers in pediatrics, 2022-08, Vol.10, p.910268-910268

2022

Link zum Volltext

Verfügbarkeit prüfen

The Small-Molecule E26-Transformation-Specific Inhibitor TK216 Attenuates the Oncogenic Properties of Pediatric Leukemia

Genes, 2023-10, Vol.14 (10), p.1916

2023

Link zum Volltext

Verfügbarkeit prüfen

Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastoma

Investigational new drugs, 2020-06, Vol.38 (3), p.690-699

2020

Link zum Volltext

Verfügbarkeit prüfen

Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells

Journal of experimental & clinical cancer research, 2015-09, Vol.34 (1), p.104, Article 104

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification of Altered Primary Immunodeficiency-Associated Genes and Their Implications in Pediatric Cancers

Cancers, 2022-11, Vol.14 (23), p.5942

2022

Link zum Volltext

Verfügbarkeit prüfen

Cannabinol Inhibits Cellular Proliferation, Invasion, and Angiogenesis of Neuroblastoma via Novel miR-34a/tRiMetF31/PFKFB3 Axis

Cancers, 2022-04, Vol.14 (8), p.1908

2022

Link zum Volltext

Verfügbarkeit prüfen

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients

Current oncology (Toronto), 2021-01, Vol.28 (1), p.346-366

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro

Metallomics, 2011-01, Vol.3 (1), p.49-55

2011

Link zum Volltext

Verfügbarkeit prüfen

Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies

Vaccines (Basel), 2022-01, Vol.10 (2), p.196

2022

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Sensitivity Profiling of Neuroblastoma Cells Against A Comprehensive Small Molecule Kinase Inhibitor Library to Identify Agents for Future Therapeutic Studies

Current cancer drug targets, 2017-01, Vol.17 (6), p.569

2017

Link zum Volltext

Verfügbarkeit prüfen

Aurora kinases as druggable targets in pediatric leukemia: heterogeneity in target modulation activities and cytotoxicity by diverse novel therapeutic agents

PloS one, 2014-07, Vol.9 (7), p.e102741-e102741

2014

Link zum Volltext

Verfügbarkeit prüfen

1118 The iodinated fluorescein derivative PV-10 enhances the antiviral activity of CD8+ T-Cells by inducing STING dimerization: implications for enhanced vaccine applications

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1231-A1231

2023

Link zum Volltext

Verfügbarkeit prüfen

17-DMAG regulates p21 expression to induce chondrogenesis in vitro and in vivo

Disease models & mechanisms, 2018-10, Vol.11 (10)

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeting Oral Squamous Cell Carcinoma with Combined Polo-Like-Kinase-1 Inhibitors and γ-Radiation Therapy

Biomedicines, 2024-02, Vol.12 (3), p.503

2024

Link zum Volltext

Verfügbarkeit prüfen

Identification and in vitro validation of neoantigens for immune activation against high-risk pediatric leukemia cells

Human vaccines & immunotherapeutics, 2021-12, Vol.17 (12), p.5558-5562

2021

Link zum Volltext

Verfügbarkeit prüfen

Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions

Drugs (New York, N.Y.), 2013-04, Vol.73 (5), p.439-461

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting EZH2-mediated methylation of histone 3 inhibits proliferation of pediatric acute monocytic leukemia cells in vitro

Cancer biology & therapy, 2021-04, Vol.22 (4), p.333-344

2021

Link zum Volltext

Verfügbarkeit prüfen

A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML

Clinical epigenetics, 2017-10, Vol.9 (1), p.108-108, Article 108

2017

Link zum Volltext

Verfügbarkeit prüfen

Temporal order of cancers and mental disorders in an adult population

BJPsych open, 2018-05, Vol.4 (3), p.95-105

2018

Link zum Volltext

Verfügbarkeit prüfen

Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors

Molecular oncology, 2013-10, Vol.7 (5), p.944-954

2013

Link zum Volltext

Verfügbarkeit prüfen

Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition

Cancer cell international, 2011-12, Vol.11 (1), p.44-44, Article 44

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(128)

Publikationsform

Artikel
(138)

Sprache

Englisch
(138)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(19)
Pediatric Blood & Cancer
(10)
Journal Of Clinical Oncology
(8)
Metallomics
(7)
Neuro-Oncology
(7)
Cancer Research
(6)
Cancers
(3)
Journal Of Pediatric Hematology/oncology
(3)
Molecular Cancer Therapeutics
(3)
Oncotargets And Therapy
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Survivin as a preferential target for cancer therapy

The Developmental Origins of Cancer: A Review of the Genes Expressed in Embryonic Cells with Implications for Tumorigenesis

Development and validation of a 21-gene prognostic signature in neuroblastoma

The hepatocyte growth factor/mesenchymal epithelial transition factor axis in high-risk pediatric solid tumors and the anti-tumor activity of targeted therapeutic agents

The Small-Molecule E26-Transformation-Specific Inhibitor TK216 Attenuates the Oncogenic Properties of Pediatric Leukemia

Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastoma

Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells

Identification of Altered Primary Immunodeficiency-Associated Genes and Their Implications in Pediatric Cancers

Cannabinol Inhibits Cellular Proliferation, Invasion, and Angiogenesis of Neuroblastoma via Novel miR-34a/tRiMetF31/PFKFB3 Axis

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients

Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro

Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies

In Vitro Sensitivity Profiling of Neuroblastoma Cells Against A Comprehensive Small Molecule Kinase Inhibitor Library to Identify Agents for Future Therapeutic Studies

Aurora kinases as druggable targets in pediatric leukemia: heterogeneity in target modulation activities and cytotoxicity by diverse novel therapeutic agents

1118 The iodinated fluorescein derivative PV-10 enhances the antiviral activity of CD8+ T-Cells by inducing STING dimerization: implications for enhanced vaccine applications

17-DMAG regulates p21 expression to induce chondrogenesis in vitro and in vivo

Targeting Oral Squamous Cell Carcinoma with Combined Polo-Like-Kinase-1 Inhibitors and γ-Radiation Therapy

Identification and in vitro validation of neoantigens for immune activation against high-risk pediatric leukemia cells

Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions

Targeting EZH2-mediated methylation of histone 3 inhibits proliferation of pediatric acute monocytic leukemia cells in vitro

A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML

Temporal order of cancers and mental disorders in an adult population

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-N-Allylamino-17-Demethoxygeldanamycin in Pediatric Patients with Recurrent or Refractory Solid Tumors: A Pediatric Oncology Experimental Therapeutics Investigators Consortium Study

Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors

Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition

Suchergebnisse filtern